CTOs on the Move

Innovation

www.innovat.com

 
Innovation is the leading provider of Pharmacy Intelligence™ and pharmacy automation to the retail, hospital, government, and mail order pharmacy markets. Our PharmASSIST® suite of pharmacy automation and process optimization solutions enable all types of pharmacies to increase operational efficiency, enhance patient safety, and provide a higher quality of patient care. Leveraging our unparalleled Pharmacy Intelligence, you can optimize your pharmacy fulfillment process, develop a proven ROI, and gain complete confidence in your automation decisions before investing. Innovation is a name we carry proudly. It is what we do and in many ways who we are. For three and a ...
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.innovat.com
  • 711 Innovation Way
    Johnson City, NY USA 13790
  • Phone: 607.798.9376

Executives

Name Title Contact Details

Similar Companies

Marquez Process Service

Marquez Process Service is a Bellingham, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Contract Pharmaceuticals Limited

CPL is a leading contract development and manufacturing organization (CDMO) that provides development, manufacturing, packaging, and testing of non-sterile liquid and semi-solid pharmaceutical and regulated OTC products.

Refresh Mental Health

Refresh Mental Health is the parent company of premiere outpatient mental health, substance abuse & eating disorder practices across the United States.

Global Animal Management

Global Animal Management is a Union, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nektar

Nektar Therapeutics is a research-based development stage biopharmaceutical company that discovers and develops innovative medicines in areas of high unmet medical need. Our R&D pipeline of new investigational drugs includes treatments for cancer, auto-immune disease and chronic pain. We leverage Nektar`s proprietary and proven chemistry platform in the discovery and design of our new drug candidates.